Immucor (BLUD): Shares define bullish 'flag' pattern

Filed under: Earnings reports, Technical Analysis, Stocks to Buy

Immucor (NASDAQ: BLUD) provides automated systems used by hospitals, clinical laboratories and blood banks to detect and identify certain properties of the cell and serum components of human blood prior to transfusion. Products are primarily used to type blood and detect foreign antibodies. Immucor sells its systems and reagent tests directly in North America, Western Europe and Japan.

The company made news earlier in the week, when it reported Q3 EPS of 27 cents and revenues of $67.3 million. Analysts had been looking for 22 cents and $62.9 million. Management also guided FY08 EPS to at least 96 cents (92 cent consensus) and FY08 revenues to at least $257 million ($255.89M consensus).

Continue reading Immucor (BLUD): Shares define bullish 'flag' pattern

<map name="google_